Europe, MEA Substance Abuse Treatment Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 9.00 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe, MEA Substance Abuse Treatment Market Analysis
The Europe, Middle East, and Africa substance abuse treatment market is expected to witness a CAGR of 9.0% over the forecast period.
- COVID-19 had a significant impact on the Europe, Middle East, and Africa substance abuse treatment market since there was a big increase in binge drinking during COVID-19. For instance, as per the February 2021 update by Randox Technology, the impact of COVID-19 on drug usage in Europe varied depending on the drug in consideration. Overall, 51.6% of survey respondents reported increasing their drug or alcohol intake, and 57.3% reported using drugs more often.
- The main explanations for these trends are boredom and anxiety, most likely as a result of the imposed limits of severe lockdown measures. However, as the pandemic restrictions eased, the Europe, Middle East, and Africa substance abuse treatment market is expected to witness growth in the market due to the increase in awareness campaigns regarding substance abuse and the increase in substance dependence among the population.
- Certain factors that are driving the market growth include rising drug awareness campaigns and prevention programs, a high number of addicted populations, and a rise in research and development of substance abuse treatment. For instance, as per the European Drug Report 2022, approximately 83.4 million or 29 % of adults (aged 15-64) in the European Union were estimated to use an illicit drug, with more males (50.5 million) than females (33.0 million) reporting use. Cannabis remains the most widely consumed substance, with over 22 million European adults reporting its use in 2021. Hence, a high number of substances used in the European region is expected to increase the demand for substance abuse treatment over the forecast period.
- Furthermore, the rise in drug awareness campaigns and associated prevention programs is one of the primary factors linked to the growth of the market studied. It includes rising patient awareness, a higher treatment-seeking rate with increased government intervention, and encouragement to curb substance abuse in several countries. For instance, in May 2021, the National Rehabilitation Centre (NRC), a World Health Organization (WHO) Collaborating Centre of Excellence in the field of substance abuse in the Middle East, organized a capacity-building training event in the field of drug and alcohol abuse prevention.
- Additionally, an increasing number of treatment centers that have collaborations with private recovery facilities are entering the market, thus helping in the expansion of treatment access to a higher number of people in society. For instance, in October 2022, the Gauteng Provincial Government launched the substance abuse helpline in line with Premier Panyaza Lesufi's commitment to intensify the fight against substance abuse across Gauteng.
- Hence, due to the increase in substance use and a rise in awareness programs against drug abuse, the studied market is likely to witness significant growth over the forecast period. However, the discontinuation of behavioral therapies and poor treatment compliance in some countries hinder the growth of the market studied.
Europe, MEA Substance Abuse Treatment Market Trends
Nicotine Replacement Treatment is Expected to Hold Significant Market Share in the Tobacco/Nicotine Addiction Treatment Segment
- Nicotine replacement therapy is a medically approved method of treating persons who have a tobacco use disorder by administering nicotine via a method other than tobacco. It is used to aid in the cessation of smoking or chewing tobacco. The nicotine replacement therapy segment is expected to hold a significant market share owing to factors such as an increase in tobacco use and a rise in awareness programs demonstrating the outcome of tobacco use.
- For instance, as per the Bill and Melinda Gates Foundation, Global Progress and Projections for Smoking, the age-standardized smoking prevalence among people ages 15 and older in Central Europe was 30% in 2021. Whereas in North Africa and the Middle East, the age-standardized smoking prevalence among people ages 15 and older was 19% in 2021.
- Nicotine replacement therapy (NRT) offers nicotine in the form of gum, patches, sprays, inhalers, or lozenges without other harmful chemicals in tobacco. The rise in product approvals and product launches in Europe and the Middle East is likely to drive market growth.
- For instance, in November 2022, Qnovia, Inc., a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement therapy (NRT) and cardiopulmonary diseases, publicized their intention to pursue UK licensing by the Medicines and Healthcare Products Regulatory Agency (MHRA) as a medicine to aid in smoking cessation.
- Thus, due to the increase in tobacco use and a rise in product launches, the studied segment is likely to witness significant growth over the forecast period.
Europe is Anticipated to Hold a Significant Share in the Market Over the Forecast Period
In Europe, the United Kingdom is expected to witness notable market growth owing to the factors such as an increase in the prevalence of drug use, a rise in substance abuse awareness programs, and a surge in drug abuse treatment options across the region.
For instance, as per the Drug Misuse in England and Wales: year ending June 2022, the percentage of adults reporting drug use in the age groups of 16 to 59 years was 9.2%, or roughly 3 million adults, and 16 to 24 years was 18.6% or roughly 1.1 million adults in 2022. Hence, a rise in the utilization of drugs among the UK population increases the demand for deaddiction and treatment, thereby driving the market growth.
Moreover, an increase in awareness programs conducted by government agencies and key players is expected to drive market growth in the United Kingdom. For instance, in October 2022, Action on Addiction conducted its annual awareness week to address the complex causes of addiction and challenge the stigma surrounding it. In 2022, they focused on why addiction awareness matters and how tackling stigma and misunderstanding will help more people and families access the help they need. Hence, such campaigns to educate people regarding the harmful results of drug abuse and addiction are expected to increase the demand for substance abuse treatment over the forecast period. Furthermore, as per the December 2021 update by the Government of the UK, the Government funded GBP 780 million to rebuild the drug treatment system, in which the investment underpins a new ten-year strategy to tackle the scourge of drugs and prevent crime. The strategy also focused on every local authority in England to receive extra funding to combat drug and alcohol misuse over the next three years, with areas in greatest need receiving extra funding first.
Thus, due to the increase in substance use and a rise in awareness programs, the United Kingdom is likely to witness significant growth over the forecast period.
Europe, MEA Substance Abuse Treatment Industry Overview
The market is highly competitive and consists of several major players. Companies like Alkermes PLC, Abbvie (Allergan), GSK plc, Mallinckrodt LLC, Viatris, Pfizer Inc., Purdue Pharma LP, Sanofi, and Teva Pharmaceutical Industries Ltd, among others, hold a substantial share in the market studied.
Europe, MEA Substance Abuse Treatment Market Leaders
-
Mallinckrodt LLC
-
Indivior PLC
-
Alkermes PLC
-
Viatris
-
GSK plc
*Disclaimer: Major Players sorted in no particular order
Europe, MEA Substance Abuse Treatment Market News
- March 2023: The National Institute for Health and Care Research (NIHR) funded GBP 5 million (USD 6.9 million) for five projects aimed at reducing recreational drug use. Projects for phase 1 are based in Huddersfield, Derbyshire, Manchester, Dorset, and the South East of England and will include schemes tailored to meet local needs.
- June 2022: The Dubai Police General Command inaugurated a three-day campaign using an interactive platform at the Dubai Mall. The campaign, themed "Drugs ... A Painful Ending," was organized in observance of the International Day against Drug Abuse and Illicit Trafficking.
Europe, MEA Substance Abuse Treatment Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Drug Awareness Campaigns and Prevention Programs
- 4.2.2 High Number of Drug Addicted Population
- 4.2.3 Rise in Research and Development for the Substance Abuse Treatment
-
4.3 Market Restraints
- 4.3.1 Reluctance of Individuals for Accessing Treatment and Discontinuation of the Behavioral Therapies
- 4.3.2 Poor Treatment Compliance in Some Countries
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Abuse Type
- 5.1.1 Alcohol Dependence
- 5.1.2 Tobacco/Nicotine Addiction
- 5.1.3 Opioid Addiction
- 5.1.4 Other Abuse Types
-
5.2 By Treatment
- 5.2.1 Alcohol Addiction Treatment
- 5.2.2 Tobacco/Nicotine Addiction Treatment
- 5.2.2.1 Nicotine Replacement Treatment
- 5.2.2.2 Non-nicotine Medication
- 5.2.2.3 Other Tobacco/Nicotine Addiction Treatments
- 5.2.3 Drug Abuse Treatment
- 5.2.4 Other Treatment Types
-
5.3 By Distribution Channel
- 5.3.1 Hospital Pharmacies
- 5.3.2 Retail Pharmacies
- 5.3.3 Other Distribution Channels
-
5.4 Geography
- 5.4.1 Europe
- 5.4.1.1 Germany
- 5.4.1.2 United Kingdom
- 5.4.1.3 France
- 5.4.1.4 Italy
- 5.4.1.5 Spain
- 5.4.1.6 Rest of Europe
- 5.4.2 Middle East and Africa
- 5.4.2.1 GCC
- 5.4.2.2 South Africa
- 5.4.2.3 Rest of Middle East and Africa
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Alkermes PLC
- 6.1.2 AbbVie Inc. (Allergan)
- 6.1.3 GSK plc
- 6.1.4 Mallinckrodt LLC
- 6.1.5 Viatris
- 6.1.6 Pfizer Inc
- 6.1.7 Purdue Pharma LP
- 6.1.8 Sanofi
- 6.1.9 Teva Pharmaceutical Industries Ltd
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Europe, MEA Substance Abuse Treatment Industry Segmentation
Substance abuse refers to the use of psychoactive substances, including illicit drugs, tobacco, and alcohol. Excessive use of a psychoactive substance can lead to major health and social issues, which, in some cases, can even lead to critical ailments and death.
The Europe, Middle East, and Africa substance abuse treatment market is segmented by abuse type (alcohol dependence, tobacco/nicotine addiction, opioid addiction, other abuse types), treatment (alcohol addiction treatment, tobacco/nicotine addiction treatment (nicotine replacement treatment, non-nicotine medication, other tobacco/nicotine addiction treatments), drug abuse treatment, other treatment types), distribution channel (hospital pharmacies, retail pharmacies, other distribution channels), and geography (Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Middle East and Africa (GCC, South Africa, Rest of Middle East and Africa)).
The report offers the value (in USD) for the above segments.
| By Abuse Type | Alcohol Dependence | |
| Tobacco/Nicotine Addiction | ||
| Opioid Addiction | ||
| Other Abuse Types | ||
| By Treatment | Alcohol Addiction Treatment | |
| Tobacco/Nicotine Addiction Treatment | Nicotine Replacement Treatment | |
| Non-nicotine Medication | ||
| Other Tobacco/Nicotine Addiction Treatments | ||
| Drug Abuse Treatment | ||
| Other Treatment Types | ||
| By Distribution Channel | Hospital Pharmacies | |
| Retail Pharmacies | ||
| Other Distribution Channels | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa |
Europe, MEA Substance Abuse Treatment Market Research FAQs
What is the current Europe, MEA Substance Abuse Treatment Market size?
The Europe, MEA Substance Abuse Treatment Market is projected to register a CAGR of 9% during the forecast period (2024-2029)
Who are the key players in Europe, MEA Substance Abuse Treatment Market?
Mallinckrodt LLC, Indivior PLC, Alkermes PLC, Viatris and GSK plc are the major companies operating in the Europe, MEA Substance Abuse Treatment Market.
What years does this Europe, MEA Substance Abuse Treatment Market cover?
The report covers the Europe, MEA Substance Abuse Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe, MEA Substance Abuse Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Europe, Middle East and Africa Substance Abuse Treatment Industry Report
Statistics for the 2024 Europe, Middle East and Africa Substance Abuse Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe, Middle East and Africa Substance Abuse Treatment analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
